JP2004517099A5 - - Google Patents

Download PDF

Info

Publication number
JP2004517099A5
JP2004517099A5 JP2002551529A JP2002551529A JP2004517099A5 JP 2004517099 A5 JP2004517099 A5 JP 2004517099A5 JP 2002551529 A JP2002551529 A JP 2002551529A JP 2002551529 A JP2002551529 A JP 2002551529A JP 2004517099 A5 JP2004517099 A5 JP 2004517099A5
Authority
JP
Japan
Prior art keywords
alkyl
formula
compound
represented
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002551529A
Other languages
English (en)
Japanese (ja)
Other versions
JP4397586B2 (ja
JP2004517099A (ja
Filing date
Publication date
Priority claimed from GBGB0031302.3A external-priority patent/GB0031302D0/en
Application filed filed Critical
Publication of JP2004517099A publication Critical patent/JP2004517099A/ja
Publication of JP2004517099A5 publication Critical patent/JP2004517099A5/ja
Application granted granted Critical
Publication of JP4397586B2 publication Critical patent/JP4397586B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002551529A 2000-12-21 2001-12-20 Ep4受容体に結合するナフタレン誘導体 Expired - Fee Related JP4397586B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0031302.3A GB0031302D0 (en) 2000-12-21 2000-12-21 Napthalene derivatives
PCT/GB2001/005676 WO2002050032A1 (en) 2000-12-21 2001-12-20 Naphthalene derivatives which bind to the ep4 receptor

Publications (3)

Publication Number Publication Date
JP2004517099A JP2004517099A (ja) 2004-06-10
JP2004517099A5 true JP2004517099A5 (US07794700-20100914-C00152.png) 2005-12-22
JP4397586B2 JP4397586B2 (ja) 2010-01-13

Family

ID=9905630

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002551529A Expired - Fee Related JP4397586B2 (ja) 2000-12-21 2001-12-20 Ep4受容体に結合するナフタレン誘導体

Country Status (9)

Country Link
US (1) US6924297B2 (US07794700-20100914-C00152.png)
EP (1) EP1351934B1 (US07794700-20100914-C00152.png)
JP (1) JP4397586B2 (US07794700-20100914-C00152.png)
AT (1) ATE371645T1 (US07794700-20100914-C00152.png)
AU (1) AU2002216218A1 (US07794700-20100914-C00152.png)
DE (1) DE60130256T2 (US07794700-20100914-C00152.png)
ES (1) ES2290093T3 (US07794700-20100914-C00152.png)
GB (1) GB0031302D0 (US07794700-20100914-C00152.png)
WO (1) WO2002050032A1 (US07794700-20100914-C00152.png)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN2001000224A (es) 2000-10-19 2002-06-13 Pfizer Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti - inflamatorios y analgesicos.
GB0031295D0 (en) * 2000-12-21 2001-01-31 Glaxo Group Ltd Naphthalene derivatives
BRPI0509993A (pt) * 2004-04-20 2007-10-16 Pfizer Prod Inc combinações compreendendo ligandos de alfa-2-delta
ATE533766T1 (de) 2005-05-19 2011-12-15 Merck Canada Inc Chinolinderivate als ep4-antagonisten
UY30121A1 (es) 2006-02-03 2007-08-31 Glaxo Group Ltd Nuevos compuestos
GB0615111D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel compounds
GB0615105D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel compounds
MX2009006474A (es) 2006-12-15 2009-06-26 Glaxo Group Ltd Derivados de benzamida como agonistas del receptor ep4.
AU2008232265B2 (en) * 2007-03-26 2013-02-28 Merck Canada Inc. Naphthalene and quinoline sulfonylurea derivatives as EP4 receptor antagonists
GB0721611D0 (en) 2007-11-02 2007-12-12 Glaxo Group Ltd Novel compounds
EP2149554A1 (de) 2008-07-30 2010-02-03 Bayer Schering Pharma Aktiengesellschaft Indolylamide als Modulatoren des EP2-Rezeptors
EP2149552A1 (de) 2008-07-30 2010-02-03 Bayer Schering Pharma AG 5,6 substituierte Benzamid-Derivate als Modulatoren des EP2-Rezeptors
EP2149551A1 (de) 2008-07-30 2010-02-03 Bayer Schering Pharma AG N-(Indol-3-ylalkyl)-(hetero)arylamidderivate als Modulatoren des EP2-Rezeptors
WO2010087425A1 (ja) 2009-01-30 2010-08-05 国立大学法人京都大学 前立腺癌の進行抑制剤および進行抑制方法
DE102009049662A1 (de) 2009-10-13 2011-04-14 Bayer Schering Pharma Aktiengesellschaft 2,5-Disubstituierte 2H-Indazole als EP2-Rezeptor-Antagonisten
EP2488168A1 (en) 2009-10-14 2012-08-22 Gemmus Pharma Inc. Combination therapy treatment for viral infections
AU2014305843B2 (en) 2013-08-09 2019-08-29 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
KR102559499B1 (ko) * 2015-01-09 2023-07-25 오노 야꾸힝 고교 가부시키가이샤 삼환성 스피로 화합물
CR20180323A (es) 2015-11-20 2018-08-06 Idorsia Pharmaceuticals Ltd Derivados de indol n-sustituídos como moduladores de los receptores de pge2
JP6269888B1 (ja) * 2016-07-07 2018-01-31 小野薬品工業株式会社 医薬用途
DK3625224T3 (da) 2017-05-18 2021-11-08 Idorsia Pharmaceuticals Ltd N-substituerede indolderivater
KR102612649B1 (ko) 2017-05-18 2023-12-11 이도르시아 파마슈티컬스 리미티드 Pge2 수용체 조절제로서의 벤조푸란 및 벤조티오페논 유도체
UA125123C2 (uk) 2017-05-18 2022-01-12 Ідорсія Фармасьютікалз Лтд Фенільні похідні як модулятори pge2 рецепторів
WO2018210988A1 (en) 2017-05-18 2018-11-22 Idorsia Pharmaceuticals Ltd Pyrimidine derivatives as pge2 receptor modulators
US11446298B2 (en) 2017-05-18 2022-09-20 Idorsia Pharmaceuticals Ltd Pyrimidine derivatives
EP3759078A1 (en) 2018-03-02 2021-01-06 Inflazome Limited Novel compounds
WO2019166633A1 (en) * 2018-03-02 2019-09-06 Inflazome Limited Sulfonamide derivates as nlrp3 inhibitors
EP3759103A1 (en) 2018-03-02 2021-01-06 Inflazome Limited Novel compounds
EP3759102A1 (en) 2018-03-02 2021-01-06 Inflazome Limited Novel compounds
WO2019166629A1 (en) 2018-03-02 2019-09-06 Inflazome Limited Novel compounds
WO2020237096A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Combination for lowering serum phosphate in a patient
US20230390303A1 (en) 2020-11-13 2023-12-07 Ono Pharmaceutical Co., Ltd. Cancer treatment by combination of ep4 antagonist and immune checkpoint inhibitor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4014899A (en) 1973-10-29 1977-03-29 Ciba-Geigy Corporation 5,6-Benzoisoindolines
US4395417A (en) 1980-04-22 1983-07-26 Research Corporation Antihyperlipidemic compositions
ID18046A (id) * 1996-08-20 1998-02-19 Takeda Chemical Industries Ltd Senyawa siklik campuran, pembuatan dan penngunaannya.
DE19650975A1 (de) 1996-12-09 1998-06-10 Basf Ag Neue heterocyclisch substituierte Benzamide und deren Anwendung
HUP0201586A2 (en) 1999-06-10 2002-08-28 Warner Lambert Co Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives

Similar Documents

Publication Publication Date Title
JP2004517099A5 (US07794700-20100914-C00152.png)
JP2004517847A5 (US07794700-20100914-C00152.png)
JP2004517098A5 (US07794700-20100914-C00152.png)
JP2009536660A5 (US07794700-20100914-C00152.png)
RU2116789C1 (ru) Способ ингибирования вирусных инфекций гепатита в
JP2005511531A5 (US07794700-20100914-C00152.png)
JP2005505618A5 (US07794700-20100914-C00152.png)
JP2019094345A5 (US07794700-20100914-C00152.png)
JP2005511532A5 (US07794700-20100914-C00152.png)
JP2005501120A5 (US07794700-20100914-C00152.png)
RU2005107314A (ru) Пиримидопроизводные, характеризующиеся антипролиферативной активностью
JP2005508337A5 (US07794700-20100914-C00152.png)
RU2004104625A (ru) Аналоги простагландинов в качестве агонистов рецептора ep4
JP2002543185A5 (US07794700-20100914-C00152.png)
JP2005509622A5 (US07794700-20100914-C00152.png)
RU2003102612A (ru) N-окиси в качестве пролекарств производных 4-фенилпиридина, являющихся натагонистами рецептора nk-1
JP2008512348A5 (US07794700-20100914-C00152.png)
JP2006526590A5 (US07794700-20100914-C00152.png)
JP2008514732A5 (US07794700-20100914-C00152.png)
MXPA04002338A (es) Derivados de carbazol y su uso como antagonistas receptores del npy5.
JP2011509309A5 (US07794700-20100914-C00152.png)
JP2005508967A5 (US07794700-20100914-C00152.png)
JP2006523193A5 (US07794700-20100914-C00152.png)
JP2004517843A5 (US07794700-20100914-C00152.png)
JP2006507355A5 (US07794700-20100914-C00152.png)